L-796,778

Term ID

CHEBI:192264

Synonyms

L 796778
L-796778
L796778
methyl (2S)-6-amino-2-[[(2R)-2-[[(2S)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoylamino]hexanoyl]amino]hexanoate
methyl (2S)-6-amino-2-{[(2R)-2-({[(2S)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl}amino)hexanoyl]amino}hexanoate
methyl N-{[(2S)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl}-D-norleucyl-L-lysinate

Definition

A methyl ester resulting from the formal condensation of the carboxy group of N-{[(2S)-1-(4-nitroanilino)-1-oxo-3-phenylpropan-2-yl]carbamoyl}-D-norleucyl-L-lysine with methanol. It is a partial agonist of somatostatin subtype receptor 3 (Ki = 24 nM) that exhibits anticonvulsant effects.

References

Ontology

ChEBI ( EBI )

Relationships

is a type of: benzenes C-nitro compound L-lysine derivative L-phenylalanine derivative methyl ester ... Show All 8 Terms

benzenes C-nitro compound L-lysine derivative L-phenylalanine derivative methyl ester oligopeptide secondary carboxamide ureas Show first 5 Terms
has_role: somatostatin receptor agonist

somatostatin receptor agonist Show first 5 Terms

Phenotype

Phenotype resulting from L-796,778

Phenotype where environments contain L-796,778

Phenotype modified by environments containing L-796,778

Human Disease Model